EFDID: 84323EFD: View Filing

Issuer: Lion Biotechnologies, Inc. (0001425205) - D

Accession: 0001250853-13-000113 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0001425205
  • Entity Name:
    Lion Biotechnologies, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    NEVADA
  • Year of Inc:
    Over 5 years ago
  • Address:
    21900 BURBANK BLVD.
    THIRD FLOOR
    WOODLAND HILLS, CA 91367
  • Persons:
    Related Persons 5
    Manish Singh
    Executive OfficerDirector
    Jay Venkatesan
    Director
    Sanford Hillsberg
    Director
    Merrill McPeak
    Director
    Michael Handelman
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    11/14/2013
  • First Sale Date:
    11/05/2013
  • Offering Amount:
    $23,290,600
  • Amount Sold:
    $23,290,600
  • Exemptions:
    Rule 506
  • Security Type(s):
    Equity
EFD: Current State Notices

No State Notices found in EFD

EDGAR: Sales Compensation Recipient Information
RecipientCRDBroker DealerBD CRDStates
Roth Capital Partners, LLC 15407 None None CA
Scarsdale Equities LLC 134602 None None NY
American Portfolio Financial Services, Inc. 18487 None None AZ, CA, CO, CT, FL, GA, IL, IN, IA, KY, MD, MI, NJ, NM, NY, NC, OH, OR, PA, TN
Agincourt, Ltd. 36661 None None
EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Lion Biotechnologies, Inc./s/ Manish SinghManish SinghChief Executive Officer2013-11-14